Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BGB-53038 |
Trade Name | |
Synonyms | BGB 53038|BGB53038 |
Drug Descriptions |
Limited information is currently available on BGB-53038, a putative pan KRAS inhibitor (Dec 2024). |
DrugClasses | KRAS Inhibitor 19 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BGB-53038 | BGB-53038 | 0 | 1 |
BGB-53038 + Cetuximab | BGB-53038 Cetuximab | 0 | 1 |
BGB-53038 + Tislelizumab | BGB-53038 Tislelizumab | 0 | 1 |